HeartBeam Inc. (NASDAQ: BEAT) announced it has received a new U.S. patent that expands the capabilities of its credit card-sized, cable-free ECG device to include acoustic sensing and thoracic impedance measurement. This patent strengthens the company's intellectual property portfolio and supports future applications in monitoring structural heart disease and heart failure.
The patent covers the integration of a digital stethoscope function and the ability to assess fluid accumulation in the chest, enabling earlier detection of heart valve abnormalities and fluid congestion in heart failure patients. Importantly, these capabilities are added without altering the device's existing form factor, maintaining its portability and patient-operated design.
HeartBeam's CEO commented that the patent advances the company's strategy of developing a multi-modal ambulatory cardiac sensing platform. The company's global patent portfolio now includes 26 issued patents, covering signal acquisition, ECG synthesis algorithms, diagnostic applications, and device hardware. The full press release is available at https://ibn.fm/jgVf0.
HeartBeam's technology is designed to collect ECG signals in 3D from three non-coplanar directions and synthesize them into a 12-lead ECG. The platform received FDA clearance for arrhythmia assessment in December 2024 and for 12-lead ECG synthesis software in December 2025. The company's cleared indications for use can be found at https://www.heartbeam.com/indications.
The announcement underscores HeartBeam's focus on transforming cardiac care by enabling actionable heart intelligence outside of medical facilities. This expansion into heart failure and structural heart disease monitoring could address significant unmet needs, as these conditions often require frequent monitoring and early intervention. The company's patent portfolio now covers a broad range of technologies essential for ambulatory cardiac monitoring.
Investors seeking the latest updates on BEAT can access the company's newsroom at https://ibn.fm/BEAT. HeartBeam is a medical technology company committed to redefining cardiac health management through portable, cable-free devices that deliver continuous monitoring capabilities.
